Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$22.51 - $30.11 $1.58 Million - $2.11 Million
-70,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$12.65 - $29.57 $885,500 - $2.07 Million
70,000 New
70,000 $1.89 Million
Q4 2019

Feb 14, 2020

SELL
$13.02 - $19.5 $260,400 - $390,000
-20,000 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$17.46 - $29.05 $349,200 - $581,000
20,000 New
20,000 $362,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.